Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Study shows increasing number of U.S. adults are taking antidepressants and antipsychotic medications

Study shows increasing number of U.S. adults are taking antidepressants and antipsychotic medications

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

DSPA submits lurasidone NDA to the FDA

DSPA submits lurasidone NDA to the FDA

First animal model for studying schizophrenia

First animal model for studying schizophrenia

Intra-Cellular Therapies announces results of its ITI-007 antipsychotic drug Phase I study

Intra-Cellular Therapies announces results of its ITI-007 antipsychotic drug Phase I study

Antidepressants may play a key role in improving adolescents’ mental health

Antidepressants may play a key role in improving adolescents’ mental health

ZYPREXA RELPREVV approved by FDA

ZYPREXA RELPREVV approved by FDA

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Antiepileptic drugs may have a possible protective effect against seizure disorders

Antiepileptic drugs may have a possible protective effect against seizure disorders

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves once-daily SEROQUEL XR Extended Release Tablets

FDA approves once-daily SEROQUEL XR Extended Release Tablets

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Galenea and Otsuka Pharmaceutical extend their research and development collaboration

Galenea and Otsuka Pharmaceutical extend their research and development collaboration

Antipsychotic medications increase the levels of inflammation markers, find researchers

Antipsychotic medications increase the levels of inflammation markers, find researchers

Behavior problems in children with autism can be reduced with a training program for parents

Behavior problems in children with autism can be reduced with a training program for parents

Pharmacy-based intervention improves antipsychotic adherence among patients with mental illnesses

Pharmacy-based intervention improves antipsychotic adherence among patients with mental illnesses

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

FDA approves sNDA for pediatric autism drug ABILIFY

FDA approves sNDA for pediatric autism drug ABILIFY

New research provides valuable international profile of mental health disorder

New research provides valuable international profile of mental health disorder

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.